About Us
Fresenius Kabi Oncology Limited at a glance
Fresenius Kabi Oncology Limited, a wholly owned subsidiary of Fresenius Kabi, is a leading player in oncology generics segment based on the strength of its comprehensive product portfolio of injectables, oral, cytotoxics, cytostatics, intermediates and Active Pharmaceutical Ingredients (APIs).
With the generic oncology products portfolio, Fresenius Kabi Oncology Limited offers an integrated approach to cancer therapy. Globally, this includes I.V. solutions and drugs, devices, parenteral and enteral nutrition, compounding services and home care. Our competitively priced portfolio of generic I.V. and oral formulations compliments our existing range of oncology products and services.
Fresenius Kabi Oncology Limited, a wholly owned subsidiary of Fresenius Kabi, is a leading player in oncology generics segment based on the strength of its comprehensive product portfolio of injectables, oral, cytotoxics, cytostatics, intermediates and Active Pharmaceutical Ingredients (APIs).
With the generic oncology products portfolio, Fresenius Kabi Oncology Limited offers an integrated approach to cancer therapy. Globally, this includes I.V. solutions and drugs, devices, parenteral and enteral nutrition, compounding services and home care. Our competitively priced portfolio of generic I.V. and oral formulations compliments our existing range of oncology products and services.
| Corporate Office: |
FRESENIUS KABI ONCOLOGY LIMITED
Plot No. 11, Sector-32 |
| Research and Development Center: |
FRESENIUS KABI ONCOLOGY LIMITED
Plot No. 11, Sector-32 |
| Registered Office: |
FRESENIUS KABI ONCOLOGY LIMITED
B-310, Som Datt Chambers-1 |
